We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Corteva, Inc. (CTVA) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
Read MoreHide Full Article
The upcoming report from Corteva, Inc. (CTVA - Free Report) is expected to reveal quarterly earnings of $2.24 per share, indicating an increase of 1.8% compared to the year-ago period. Analysts forecast revenues of $6.62 billion, representing an increase of 2.6% year over year.
The consensus EPS estimate for the quarter has undergone a downward revision of 89.9% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Bearing this in mind, let's now explore the average estimates of specific Corteva, Inc. metrics that are commonly monitored and projected by Wall Street analysts.
According to the collective judgment of analysts, 'Net Sales- Crop Protection' should come in at $1.93 billion. The estimate suggests a change of +0.5% year over year.
Analysts predict that the 'Net Sales- Seed' will reach $4.66 billion. The estimate suggests a change of +2.7% year over year.
The consensus among analysts is that 'Net Sales- Seed- Other oilseeds' will reach $223.97 million. The estimate indicates a year-over-year change of +20.4%.
The average prediction of analysts places 'Net Sales- Crop Protection- Herbicides' at $1.01 billion. The estimate indicates a year-over-year change of +1%.
The combined assessment of analysts suggests that 'Net Sales- Crop Protection- Insecticides' will likely reach $436.24 million. The estimate indicates a change of +0.1% from the prior-year quarter.
It is projected by analysts that the 'Net Sales- Crop Protection- Fungicides' will reach $326.08 million. The estimate points to a change of -4.7% from the year-ago quarter.
Based on the collective assessment of analysts, 'Net Sales- Crop Protection- Other' should arrive at $57.90 million. The estimate points to a change of +18.2% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Net Sales- Seed- Soybean' of $1.40 billion. The estimate indicates a year-over-year change of +11.2%.
Analysts forecast 'Net Sales- Seed- Corn' to reach $2.83 billion. The estimate points to a change of -4.4% from the year-ago quarter.
Analysts expect 'Net Sales- Seed- Other' to come in at $162.14 million. The estimate indicates a change of +21.9% from the prior-year quarter.
Analysts' assessment points toward 'Operating EBITDA- Seed' reaching $1.92 billion. The estimate is in contrast to the year-ago figure of $1.86 billion.
The consensus estimate for 'Operating EBITDA- Crop Protection' stands at $324.27 million. Compared to the present estimate, the company reported $334.00 million in the same quarter last year.
Over the past month, shares of Corteva, Inc. have returned +5.1% versus the Zacks S&P 500 composite's +1.7% change. Currently, CTVA carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Corteva, Inc. (CTVA) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
The upcoming report from Corteva, Inc. (CTVA - Free Report) is expected to reveal quarterly earnings of $2.24 per share, indicating an increase of 1.8% compared to the year-ago period. Analysts forecast revenues of $6.62 billion, representing an increase of 2.6% year over year.
The consensus EPS estimate for the quarter has undergone a downward revision of 89.9% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Bearing this in mind, let's now explore the average estimates of specific Corteva, Inc. metrics that are commonly monitored and projected by Wall Street analysts.
According to the collective judgment of analysts, 'Net Sales- Crop Protection' should come in at $1.93 billion. The estimate suggests a change of +0.5% year over year.
Analysts predict that the 'Net Sales- Seed' will reach $4.66 billion. The estimate suggests a change of +2.7% year over year.
The consensus among analysts is that 'Net Sales- Seed- Other oilseeds' will reach $223.97 million. The estimate indicates a year-over-year change of +20.4%.
The average prediction of analysts places 'Net Sales- Crop Protection- Herbicides' at $1.01 billion. The estimate indicates a year-over-year change of +1%.
The combined assessment of analysts suggests that 'Net Sales- Crop Protection- Insecticides' will likely reach $436.24 million. The estimate indicates a change of +0.1% from the prior-year quarter.
It is projected by analysts that the 'Net Sales- Crop Protection- Fungicides' will reach $326.08 million. The estimate points to a change of -4.7% from the year-ago quarter.
Based on the collective assessment of analysts, 'Net Sales- Crop Protection- Other' should arrive at $57.90 million. The estimate points to a change of +18.2% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Net Sales- Seed- Soybean' of $1.40 billion. The estimate indicates a year-over-year change of +11.2%.
Analysts forecast 'Net Sales- Seed- Corn' to reach $2.83 billion. The estimate points to a change of -4.4% from the year-ago quarter.
Analysts expect 'Net Sales- Seed- Other' to come in at $162.14 million. The estimate indicates a change of +21.9% from the prior-year quarter.
Analysts' assessment points toward 'Operating EBITDA- Seed' reaching $1.92 billion. The estimate is in contrast to the year-ago figure of $1.86 billion.
The consensus estimate for 'Operating EBITDA- Crop Protection' stands at $324.27 million. Compared to the present estimate, the company reported $334.00 million in the same quarter last year.
View all Key Company Metrics for Corteva, Inc. here>>>Over the past month, shares of Corteva, Inc. have returned +5.1% versus the Zacks S&P 500 composite's +1.7% change. Currently, CTVA carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .